Can iron chelation as an adjunct treatment of COVID-19 improve the clinical outcome?

被引：28
|
作者：
Abobaker, Anis [1 ]
机构：
[1] Spire Fylde Coast Hosp, St Walburgas Rd, Blackpool FY3 8BP, England
来源：
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY | 2020年 / 76卷 / 11期
关键词：
INFECTION; DEFEROXAMINE; CELLS;
D O I：
10.1007/s00228-020-02942-9
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1619 / 1620
页数：2
相关论文
共 50 条
  • [31] Lithium salts as a treatment for COVID-19: Pre-clinical outcomes
    Soriano-Torres, O.
    Romero, E. Noa
    Sosa, N. L. Gonzalez
    Puertas, J. M. Enriquez
    Quintero, A. Fragas
    Montero, M. Garcia
    Alfonso, D. Martin
    Hernandez, Y. Infante
    Lastre, M.
    Rodriguez-Perez, L.
    Borrego, Y.
    Gonzalez, V. E.
    Vega, I. G.
    Pupo, R. Ramos
    Reyes, L. M.
    Dube, M. T. Zumeta
    Hernandez, I. Amaro
    de la Rosa, I. Garcia
    Suarez, A. Minguez
    Camejo, L. A. Alarcon
    Rodriguez, M.
    Hernandez, R. Oliva
    Rudd, C. E.
    Perez, O.
    BIOMEDICINE & PHARMACOTHERAPY, 2022, 149
  • [32] Iron dysregulation and inflammatory stress erythropoiesis associates with long-term outcome of COVID-19
    Hanson, Aimee L.
    Mule, Matthew P.
    Ruffieux, Helene
    Mescia, Federica
    Bergamaschi, Laura
    Pelly, Victoria S.
    Turner, Lorinda
    Kotagiri, Prasanti
    Gottgens, Berthold
    Hess, Christoph
    Gleadall, Nicholas
    Bradley, John R.
    Nathan, James A.
    Lyons, Paul A.
    Drakesmith, Hal
    Smith, Kenneth G. C.
    NATURE IMMUNOLOGY, 2024, 25 (03) : 471 - 482
  • [33] COVID-19: Current understanding of its Pathophysiology, Clinical presentation and Treatment
    Parasher, Anant
    POSTGRADUATE MEDICAL JOURNAL, 2021, 97 (1147) : 312 - 320
  • [34] Neutrophils and Lymphocytes Can Help Distinguish Asymptomatic COVID-19 From Moderate COVID-19
    Gu, Xuefeng
    Sha, Ling
    Zhang, Shaofeng
    Shen, Duo
    Zhao, Wei
    Yi, Yongxiang
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2021, 11
  • [35] Covid-19 treatment update: follow the scientific evidence
    Becker, Richard C.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2020, 50 (01) : 43 - 53
  • [36] Repurposing of chlorpromazine in COVID-19 treatment: the reCoVery study
    Plaze, M.
    Attali, D.
    Petit, A-C
    Blatzer, M.
    Simon-Loriere, E.
    Vinckier, F.
    Cachia, A.
    Chretien, F.
    Gaillard, R.
    ENCEPHALE-REVUE DE PSYCHIATRIE CLINIQUE BIOLOGIQUE ET THERAPEUTIQUE, 2020, 46 (03): : S35 - S39
  • [37] Clinical characteristics and risk factors associated with severe disease and outcome of patients with COVID-19
    Ozel, Ayse Serra
    Altunal, Lutfiye Nilsun
    Aydin, Mehtap
    Unal, Busra
    Cam, Gulsum
    Ozer, Merve Caglar
    Korten, Volkan
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2022, 16 (03): : 435 - 444
  • [38] COVID-19: Time for a clinical classification?
    Jothimani, Dinesh
    Venugopal, Radhika
    Manoharan, Shruthi
    Danielraj, Silas
    Palanichamy, Swetha
    Narasimhan, Gomathy
    Kaliamoorthy, Ilankumaran
    Rela, Mohamed
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2022, 65 (04) : 902 - 906
  • [39] COVID-19 Pathogenesis and Clinical Manifestations
    Acosta, R. Alfonso Hernandez
    Garrigos, Zerelda Esquer
    Marcelin, Jasmine R.
    Vijayvargiya, Prakhar
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2022, 36 (02) : 231 - 249
  • [40] Clinical features of neonatal COVID-19
    Galderisi, Alfonso
    Lista, Gianluca
    Cavigioli, Francesco
    Trevisanuto, Daniele
    SEMINARS IN FETAL & NEONATAL MEDICINE, 2023, 28 (02)
12345